Table 2:
Unstable angina (n = 208) | NSTEMI (n = 5,947) | STEMI (n = 586) | p value | |
---|---|---|---|---|
N | 208 | 5,947 | 586 | |
Age, yrs | 82.7 ± 7.7 | 80.6 ± 8.8 | 80.9 ± 9.1 | 0.003 |
Male | 56.7 | 55.7 | 50.5 | 0.05 |
Other | - | 3.7 | 2.2 | |
Hypertension | 94.2 | 95.0 | 95.6 | 0.73 |
Diabetes mellitus | 43.8 | 51.9 | 50.7 | 0.07 |
Heart failure | 83.2 | 84.1 | 82.9 | 0.74 |
Deficiency anemia | 46.6 | 50.3 | 51.4 | 0.50 |
Alcohol abuse | - | 1.7 | 1.9 | 0.37 |
Connective tissue disease | 5.8 | 7.8 | 8.0 | 0.54 |
Chronic lung disease | 45.2 | 44.0 | 41.1 | 0.37 |
Coagulopathy | 20.2 | 24.2 | 23.9 | 0.41 |
Depression | 21.2 | 17.8 | 15.5 | 0.16 |
Hypothyroidism | 31.3 | 25.7 | 28.7 | 0.07 |
Liver disease | - | 3.8 | 5.1 | 0.05 |
Lymphoma | - | 1.8 | 2.1 | 0.24 |
Electrolyte abnormality | 47.6 | 52.0 | 52.1 | 0.46 |
Obesity | 29.8 | 27.0 | 25.9 | 0.56 |
Paralysis | - | 4.8 | 5.6 | 0.67 |
Peripheral arterial disease | 47.6 | 46.6 | 44.2 | 0.52 |
Pulmonary hypertension | 27.4 | 25.7 | 22.0 | 0.12 |
Tumor without metastasis | 5.8 | 5.3 | 5.5 | 0.96 |
Weight loss | 6.3 | 9.6 | 9.2 | 0.26 |
Prior bleeding | 40.4 | 41.7 | 43.3 | 0.68 |
Prior stroke | 23.6 | 22.5 | 22.9 | 0.92 |
ESRD | - | 7.2 | 6.5 | 0.10 |
CKD | 31.7 | 35.0 | 32.6 | 0.32 |
Prior coronary artery disease | 93.8 | 90.6 | 91.1 | 0.30 |
Prior smoking | 44.2 | 38.7 | 36.5 | 0.15 |
Prior revascularization (within 3 yrs before TAVR) | 66.8 | 55.5 | 47.8 | <0.001 |
Prior ACS (within 1 yr before TAVR) | 18.8 | 22.0 | 18.4 | 0.08 |
Prior PCI (within 6 months before TAVR) | 14.9 | 14.8 | 15.9 | 0.77 |
Prior cardiac device | 22.6 | 17.6 | 13.3 | 0.004 |
Preexisting atrial fibrillation | 42.3 | 40.6 | 41.0 | 0.88 |
Apical TAVR | 16.8 | 13.0 | 9.6 | 0.01 |
Values are mean ± SD or %.
Cells with N <10 were suppressed with (–).
CKD = chronic kidney disease; ESRD = end-stage renal disease on dialysis; NSTEMI = non–ST-segment elevation myocardial infarction; STEMI = ST-segment elevation myocardial infarction; other abbreviations as in Table 1.